Castle Biosciences Inc. (CSTL)
NASDAQ: CSTL
· Real-Time Price · USD
22.59
0.36 (1.62%)
At close: Oct 03, 2025, 2:29 PM
1.62% (1D)
| Bid | 22.58 |
| Market Cap | 655.3M |
| Revenue (ttm) | 346.27M |
| Net Income (ttm) | -9.47M |
| EPS (ttm) | -0.34 |
| PE Ratio (ttm) | -66.44 |
| Forward PE | -12.38 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 22.78 |
| Volume | 137,891 |
| Avg. Volume (20D) | 496,174 |
| Open | 22.40 |
| Previous Close | 22.23 |
| Day's Range | 22.36 - 23.38 |
| 52-Week Range | 14.59 - 35.84 |
| Beta | 1.07 |
| Ex-Dividend Date | n/a |
About CSTL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CSTL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CSTL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsCastle Biosciences Inc. is scheduled to release its earnings on
Nov 3, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+32.83%
Castle Biosciences shares are trading higher after...
Unlock content with
Pro Subscription
1 month ago
+4.57%
Castle Biosciences shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.
1 month ago · fool.com
Castle (CSTL) Q2 Revenue Tops EstimatesCastle (CSTL) Q2 Revenue Tops Estimates
